NFKB1 and colitis: Here, our results indicated that AOS administration could significantly increase AMPK phosphorylation and inhibit NF-κB p65 activation in colonic tissues, resulting in a reduction of proinflammatory factor levels and gut injury severity in DSS-induced colitis mice.